BeiGene, Ltd.
ONC
$230.98
$2.841.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.83% | 10.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.83% | 10.43% | |||
| Cost of Revenue | 0.85% | 24.20% | |||
| Gross Profit | 18.84% | 8.03% | |||
| SG&A Expenses | 12.45% | 6.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -198.08% | -- | |||
| Total Operating Expenses | 8.12% | 12.77% | |||
| Operating Income | 47.40% | -33.07% | |||
| Income Before Tax | 51.10% | -26.72% | |||
| Income Tax Expenses | 343.50% | 15.29% | |||
| Earnings from Continuing Operations | 7.44% | -25.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.44% | -25.35% | |||
| EBIT | 47.40% | -33.07% | |||
| EBITDA | 72.13% | -43.06% | |||
| EPS Basic | 8.56% | -25.03% | |||
| Normalized Basic EPS | 50.97% | -22.54% | |||
| EPS Diluted | 8.56% | -25.03% | |||
| Normalized Diluted EPS | 50.97% | -22.54% | |||
| Average Basic Shares Outstanding | 1.23% | 0.26% | |||
| Average Diluted Shares Outstanding | 1.23% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||